Disease | attention deficit-hyperactivity disorder |
Phenotype | C0020179|huntington disease |
Sentences | 1 |
PubMedID- 24062308 | Tetrabenazine (tbz) is a non-competitive inhibitor of vmat2 that is used in the treatment of hyperkinetic disorders associated with huntington disease and tourette syndrome. |
Page: 1